Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies544
Ramona Optics
Ramona Optics offers computational microscope capable of large field-of-view and high-resolution imaging.
Sector
Subsector
Keywords
Location
total rounds
total raised
Interherence
The company specialises in developing advanced devices for the global optical microscopy market.
Sector
Subsector
Keywords
Location
Phi Optics
Phi Optics develops optical imaging systems for life sciences, medical diagnostics, nanotechnology, and semiconductor testing applications.
Sector
Subsector
Location
total rounds
total raised
Specto Photonics
Specto Photonics develops next-gen miniaturized Brillouin spectrometers.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 05.03.2019. Their latest investor Innovacorp. Their latest round Debt Financing
Atlantic Canada Opportunities Agency
Atlantic Canada Opportunities Agency helps businesses in Atlantic Canada grow and succeed.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors2
Number of lead investors
Number of investors
Innovacorp
Innovacorp is a venture capital firm that helps early stage Nova Scotia entrepreneurs commercialize their technologies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Atlantic Canada Opportunities Agency
Atlantic Canada Opportunities Agency helps businesses in Atlantic Canada grow and succeed.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders3
Peter Gregson
Peter Gregson is the co-founder at Alentic Microscience.
current job
organization founded
Peter Gregson
Christopher Barden
Dr. Barden, a serial entrepreneur, registered patent agent and computational scientist, has over fifteen years of experience in drug discovery management. He is a veteran of academia and biotech drug projects, with R&D expertise in the oncology, neurodegenerative and anti-infective spaces and business expertise in technology transfer and building investible companies. A co-founder of Treventis, he is a key architect of our proprietary “CCM” model of protein misfolding. Dr. Barden received his Ph.D. in Physical (Computational) Chemistry from the Schaefer group at University of Georgia.
current job
organization founded
Christopher Barden
Alan Fine
Alan Fine is the CEO, founder, and president of Alentic Microscience.
current job
organization founded
Alan Fine